Rock Creek Pharma (RCPI) Completes Anatabine Citrate Phase 1 Trial in U.K.

October 15, 2015 9:44 AM EDT Send to a Friend
Rock Creek Pharma (NASDAQ: RCPI) announced the successful completion of its three part Phase I clinical trial conducted in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login